HomeITRM • NASDAQ
Follow
Iterum Therapeutics PLC
Previous close
$1.59
Day range
$1.49 - $1.67
Year range
$0.62 - $2.50
Market cap
20.69M USD
Avg Volume
196.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.68M | 137.21% |
Net income | -3.88M | 86.68% |
Net profit margin | — | — |
Earnings per share | -1.20 | -179.07% |
EBITDA | -16.25M | -146.72% |
Effective tax rate | -4.33% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.89M | -44.23% |
Total assets | 39.73M | -44.48% |
Total liabilities | 36.30M | -6.95% |
Total equity | 3.43M | — |
Shares outstanding | 13.05M | — |
Price to book | 6.12 | — |
Return on assets | -91.93% | — |
Return on capital | -129.97% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -3.88M | 86.68% |
Cash from operations | -9.26M | -104.12% |
Cash from investing | 360.00K | -97.73% |
Cash from financing | 10.00K | — |
Net change in cash | -8.92M | -179.06% |
Free cash flow | -3.56M | 1.66% |
About
Founded
2015
Website
Employees
14